Chargement en cours...
PI3K at the crossroads of tumor angiogenesis signaling pathways
Tumors need blood vessels for their growth, thus providing the rationale for antiangiogenic therapy in cancer treatment. However, intrinsic and acquired resistance and low response rates have turned out to be major limitations of antiangiogenic therapy. This emphasizes the need to further understand...
Enregistré dans:
| Publié dans: | Mol Cell Oncol |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Taylor & Francis
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4905058/ https://ncbi.nlm.nih.gov/pubmed/27308431 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/23723556.2014.975624 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|